Fibrin sealant: Current and potential clinical applications

Blood Coagulation and Fibrinolysis

Volumn 7, Issue 8, 1996, Pages 737-746

  Jackson, M R ^a   MacPhee, M J ^b   Drohan, W N ^b   Alving, B M ^b  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b NONE

Author keywords

Fibrin glue; Hemostatic agents; Review

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; FIBRIN GLUE; GROWTH FACTOR; THROMBIN;

BLOOD CLOTTING; DRUG DELIVERY SYSTEM; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0030467554     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199611000-00001     Document Type: Review

References (57)

1. Sierra DH. Fibrin sealant adhesive systems: a review of their chemistry, material properties and clinical applications. J Biomat Applicat 1993; 7: 309-352.
2. Coates JB, McDetridge EM, eds. Blood Program in World War II. Washington, DC: Medical Department, Office of the Surgeon General, Department of the Army, 1964: 363-369.
3. Cronkite EP, Lozner EL, Deaver JM. Use of thrombin and fibrinogen in skin grafting. JAMA 1944; 124: 976-978.
4. Gibble JW, Ness PM. Fibrin glue: the perfect operative sealant? Transfusion 1990; 30: 741-747.
5. Matras H. Fibrin seal: the state of the art. J Oral Maxillofac Surg 1985; 43: 605-611.
6. Alving BM, Weinstein MJ, Finlayson JS, Fratantoni JC. Update on fibrin sealant in commercial use or development (letter). Transfusion 1996; 36: 845-846.
7. Marx G, Mou X, Freed R, Ben-Hur E, Yang C, Horowitz B. Protecting fibrinogen with rutin during UVC irradiation for viral inactivation. Photochem Photobiol 1996; 63: 541-546.
8. Stricker RB, Lane PK, Leffert JD, Rodgers GM, Shuman MA, Corash L. Development of antithrombin antibodies following surgery in patients with prosthetic cardiac valves. Blood 1988; 72: 1375-1380.
9. Flaherty MJ, Henderson R, Wener MH. Iatrogenic immunization with bovine thrombin: a mechanism for prolonged thrombin times after surgery. Ann Intern Med 1989; 111: 631-634.
10. Zehnder JL, Leung LLK. Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin. Blood 1990; 76: 2011-2016.
11. Nichols WL, Daniels TM, Fisher PK, Owen WG, Pineda AA, Mann KG. Antibodies to bovine thrombin and coagulation factor V associated with surgical use of topical bovine thrombin or fibrin 'glue': a frequent finding. Blood 1993; 82: 59 (abstract).
12. Banninger H, Hardegger T, Tobler A, et al. Frequent development of inhibitors of bovine thrombin and human factor V. Br J Haematol 1993; 85: 528-532.
13. Rapaport SI, Zivelin A, Minow RA, Hunter CS, Donnelly K. Clinical significance of antibodies to bovine and human thrombin and factor V after surgical use of bovine thrombin. Am J Clin Pathol 1992; 97: 84-91.
14. Christie RJ, Alving BM. Management of coagulopathy in patients with antibodies against human factor V induced by bovine factor V in topical thrombin preparations. Blood 1995; 86: 867a.
15. Ortel TL, Charles LA, Keller FG, et al. Topical thrombin and acquired coagulation factor inhibitors: clinical spectrum and laboratory diagnosis. Am J Hematol 1994; 45: 128-135.
16. Ochsner MG, Maniscalco-Theberge ME, Champion HR. Fibrin glue as a hemostatic agent in hepatic and splenic trauma. J Trauma 1990; 30: 884-887.
17. Baudo F, DeCataldo F, Landonio G, Muti G. Management of oral bleeding in haemophihc patients (letter). Lancet 1988; 2: 1082.
18. Rakocz M, Mazar A, Varon D, Spierer S, Blinder D, Martinowitz U. Dental extractions in patients with bleeding disorders. Oral Surg Oral Med Oral Pathol 1993; 75: 280-282.
19. Martinowitz U, Mazar AL, Taicher S, et al. Dental extraction for patients on oral anticoagulant therapy. Oral Surg Oral Med Oral Pathol 1990; 70: 274-277.
20. Hoots K, McLeod J, Eggers E, Berg J, Lee M, Gomperts E. Pilot study to evaluate efficacy of fibrin sealant (human) on hemostasis in hemophiliacs undergoing tooth extraction. Blood 1993; 82: 153 (abstract).
21. Rousou J, Levitsky S, Gonzalez-Lavin L, et al. Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations. A multicenter study. J Thorac Cardiovasc Surg 1989; 97: 194-203.
22. Levitsky S. Randomized clinical trial of Immuno's fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations: a multicenter study (letter). Transfusion 1996; 36: 845.
23. Matthew TL, Spotnitz WD, Kron IL, Daniel TM, Tribble CG, Nolan SP. Four years' experience with fibrin sealant in thoracic and cardiovascular surgery. Ann Thorac Surg 1990; 50: 40-44.
24. Torre M, Chiesa G, Ravini M, Vercelloni M, Belloni PA. Endoscopic gluing of bronchopleural fistula. Ann Thorac Surg 1994; 58: 901-902.
25. Milne AA, Murphy WG, Reading SJ, Ruckley CV. Fibrin sealant reduces suture line bleeding during carotid endarterectomy: a randomized trial. Eur J Vaso Endovasc Surg 1995; 10: 91-94.
26. McCready RA, Siderys H, Pittman JN, Herod GT, Halbrook HG, Fehrenbacher JW, Beckman DJ, Hormouth DA. Delayed postoperative bleeding from polytetrafluoroethylene carotid artery patches. J Vasc Surg 1992; 15: 661-663.
27. Schiele U, Kuntz G, Riegler A. Fixed combination of fibrin glue with a sheet of collagen: a 'ready-to-use' local haemostyptic agent. Surg Tech Internat 1991; 1: 120.
28. Kohno H, Nagasue N, Chang Y-C, Taniura H, Yamanoi A, Nakamura T. Comparison of topical hemostatic agents in elective hepatic resection: a clinical prospective randomized trial. World J Surg 1992; 16: 966-970.
29. Suzuki Y, Kuroda Y, Morita A, et al. Fibrin glue sealing for the prevention of pancreatic fistulas following distal pancreatectomy. Arch Surg 1995; 130: 952-955.
30. Wadström J, Gannedahl G, Wahlberg J, Frödin L. Persistent pancreatic fistula after pancreas transplantation treated with fibrin glue and octreotide. Transplantation Proceedings 1995; 27: 3491-3492.
31. D'andrea AA, Costantino V, Sperti C, Pedrazzoli S. Human fibrin sealant in pancreatic surgery: a prospective randomized study. Ital J Gastroenterol 1994; 26: 283-286.
32. Udén P, Aspegren K, Balldin G, Garne J-P, Larsson SA. Fibrin adhesive in radical mastectomy. Eur J Surg 1993; 159: 263-265.
33. Berg PL, Barina W, Born P. Endoscopic injection of fibrin glue versus polidocanol in peptic ulcer hemorrahage: a pilot study. Endoscopy 1994; 26: 528-530.
34. Lau WY, Leung KL, Zhu XL, Lam YH, Chung SCS, Li AKC. Laparoscopic repair of perforated peptic ulcer. Br J Surg 1995; 82: 814-816.
35. Herold G, Stange EF. Sclerotherapy of duodenal varices using fibrin sealant. Endoscopy 1993; 25: 371-372.
36. Makuchi M, Thai BL, Takayasu K. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 1990; 107: 521-527.
37. Nagino M, Hayakawa N, Kitagawa S, et al. Interventional embolization with fibrin glue for a large inferior mesenteric-caval shunt. Surgery 1992; 111: 580-584.
38. MacPhee M, Singh M, Brady Jr R, et al. Fibrin sealant: a versatile delivery vehicle for drugs and biologies. In: Sierra D, Saltz R, eds. Surgical Adhesives and Sealants: current technology and applications. Lancaster, PA: Technomic Publishing, 1996.
39. O'Leary M, Drohan W, MacPhee M. E.N.T. applications of antibiotic-releasing fibrin sealant. Cambridge Symposia 1996; 1: 30 (abstract).
40. Sakurai T, Nishikima N, Yamamura D, Shionoya S. Controlled release of sisomicin from fibrin glue. J Cont Rel 1992; 168: 39.
41. Deyerling W, Haverich A, Potel J, Hetzer R. A suspension of fibrin glue and antibiotic for local treatment of myocotic aneurysms in endocarditis - an experimental study. Thorac Cardiovasc Surg 1984; 32: 369.
42. R. fibrin coagulum in large cystic defects of the jaw. Int J Oral Surg 1976; 5: 111.
43. Zilch H, Lambiris E. The sustained release of cefotaxim from a fibrin-cefotaxim compound in treatment of osteitis. Arch Ortho Trauma Surg 1986; 106: 36.
44. Redl H, Schlag G, Stande G, Hirechl A, Seelich T. In vitro properties of mixtures of fibrin seal and antibiotics. Biomaterials 1983; 4: 29.
45. Haverich A, Hirt S, Karck M, Siclari F, Wahlig H. Prevention of graft infection by bonding of gentamycin to Dacron prostheses. J Vasc Surg 1992; 15: 187-193.
46. Woolverton C, Singh M, Drohan W, MacPhee M. Long-term antibiotic release from fibrin sealant. Cambridge Symposia 1996; 1: 30 (abstract).
47. Goodson J. Dental applications. In: Langer RS, Wise DL, eds. Medical Applications of Controlled Release. Vol. 11, Applications and evaluation. Boca Raton, FL: CRC Press, 1984; 115.
48. MacPhee MJ, Campagna A, Best A, Kidd R, Drohan W. Fibrin sealant as a delivery vehicle for sustained and controlled release of chemotherapy agents. In: Sierra DH, Saltz R, eds. Surgical Adhesives and Sealants: current technology and applications. Lancaster PA: Technomic Publishing, 1996.
49. Kawamura M, Trist MR. Human fibrin is a physiological delivery system for bone morphogenetic protein. Clin Ortho Rel Res 1988; 235: 302-310.
50. Glowacki J, Altobelli D, Mulliken J. Fate of mineralized and demineralized osseus implants in cranial defects. Calcif Tissue Int 1981; 33: 71.
51. Glowacki J, Kaban LB, Murray IE, Folkman J, Mulliken JB. Application of the biological principle of induced osteogenesis for craniofacial defects. Lancet 1981; 8227: 959.
52. Lasa Jr C, Holinger J, Drohan W, MacPhee M. Delivery of de-mineralized bone powder by fibrin sealant. Plastic Reconst Surg 1995; 96(6): 1-9.
53. Pratt B, Nichols E, Gauthier P, McPherson M. Effective delivery of transforming growth factor-beta using fibrin sealant. Cambridge Symposia 1996; 1: 22 (abstract).
54. Woo S, Hildebrand K, Taylor B, Fox R, Schmidt C, Suh J. Ligament healing. Cambridge Symposia 1996; 1: 23 (abstract).
55. Greisler H, Cziperle D, Kim DU, et al. Enhanced endothelialization of expanded polytetrafluoroethylene grafts by fibroblast growth factor type 1 pretreatment. Surgery 1992; 112: 244-255.
56. Ness PM, Perkins HA. Cryoprecipitate as a reliable source of fibrinogen replacement. JAMA 1979; 241: 1690-1691.
57. Jackson MR. Tissue sealants: current status, future potential. Nature Med 1996; 2: 637-638.